CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 6 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $23,000 | -42.5% | 11,570 | +0.6% | 0.00% | – |
| Q2 2021 | $40,000 | +471.4% | 11,500 | -4.2% | 0.00% | – |
| Q1 2020 | $7,000 | -41.7% | 12,000 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | +33.3% | 12,000 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -25.0% | 12,000 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -29.4% | 12,000 | 0.0% | 0.00% | – |
| Q1 2019 | $17,000 | +41.7% | 12,000 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -42.9% | 12,000 | 0.0% | 0.00% | – |
| Q3 2018 | $21,000 | -25.0% | 12,000 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | -24.3% | 12,000 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | -19.6% | 12,000 | 0.0% | 0.00% | – |
| Q4 2017 | $46,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 193,715 | $347,000 | 0.10% |
| Wealth Advisory Solutions, LLC | 156,850 | $281,000 | 0.06% |
| Horst & Graben Wealth Management LLC | 75,722 | $136,000 | 0.03% |
| Miller Investment Management, LP | 50,000 | $90,000 | 0.01% |
| Cutler Group LLC / CA | 291,300 | $112,000 | 0.01% |
| Syverson Strege & Co | 2,145 | $4,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $308,000 | 0.00% |
| HighTower Advisors, LLC | 217,623 | $389,000 | 0.00% |
| Kestra Advisory Services, LLC | 40,137 | $72,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,272,145 | $4,067,000 | 0.00% |